Emergex Vaccines: Emergex inks pact with DEKA to assess compatibility of Emergex's immunotherapeutic candidates with DEKA's intradermal therapeutic applicator

Press Release: Emergex Vaccines : Emergex Announces Authorisation from Philippines FDA to Initiate Phase I-II Clinical Trial of CoronaTcP

Press Release: Emergex Vaccines : Successful Transfer of New Drug Application (NDA), Acknowledged by U.S. FDA, from Former Zosano Pharma to Emergex for Investigational Microneedle-Based Drug Delivery Patch

Emergex Vaccines: Emergex Signs Contract of 1.79M with the UK Department of

Emergex Vaccines: Saudi Arabia's Vaccine Industrial Company advances novel infectious disease solutions

Emergex Vaccines: Emergex Reports Promising Data from Completed Swiss Phase I Trial of CoronaTcP , T Cell-Priming Immune Set-Point Candidate for Betacoronaviruses

Emergex Vaccines: Emergex and Brazil's IBMP Announce Clinical Development Collaboration for T Cell-Priming Immune Set-Point Candidates